Skip to main content
. 2022 Nov 25;6:118. doi: 10.1186/s41687-022-00523-1

Table 2.

Characteristics of study participants (n = no. of participants)

n (%)
Gender
 Men 31 (86.1%)
 Women 5 (13.8%)
Age (in years)
 Median (range) 55.5 (36–74)
Education
 Secondary 21 (58.3%)
 Higher secondary 11 (30.5%)
 Under-graduation 3 (8.3%)
 Post-graduation 1 (2.7%)
Primary Tumour Site
 Buccal mucosa 7 (19.4%)
 Tongue 6 (16.6%)
 Floor of mouth (FOM) 1 (2.7%)
 Alveolus 1 (2.7%)
 Gingivobuccal sulcus, palate, and maxilla 2 (5.5%)
 Oropharynx 5 (13.8%)
 Hypopharynx 1 (2.7%)
 Pyriform sinus 2 (5.5%)
 Larynx 6 (16.6%)
 Supra-glottis 3 (8.3%)
 Glottis 2 (5.5%)
TNM stage
 I 5 (13.8%)
 II 9 (25%)
 III 7 (19.4%)
 IV 15 (41.6%)
Type of Treatment Modality
 Definitive RT 8 (22.2%)
 Definitive CT-RT 10 (27.7%)
 Adjuvant RT 12 (33.3%)
 Adjuvant CT-RT 6 (16.6%)